TITLE

Social Ecological Predictors of Longitudinal HIV Treatment Adherence in Youth With Perinatally Acquired HIV

AUTHOR(S)
Naar-King, Sylvie; Montepiedra, Grace; Garvie, Patricia; Kammerer, Betsy; Malee, Kathleen; Sirois, Patricia A.; Aaron, Lisa; Nichols, Sharon L.
PUB. DATE
July 2013
SOURCE
Journal of Pediatric Psychology;Jul2013, Vol. 38 Issue 6, p664
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective To apply a social ecological model to explore the psychosocial factors prospectively associated with longitudinal adherence to antiretroviral treatment in youth perinatally infected with HIV. Methods Randomly selected youth, age 8 to <19 years old, completed cognitive testing and psychosocial questionnaires at baseline as part of a multisite protocol (N = 138). A validated caregiver-report measure of adherence was completed at baseline and 24 and 48 weeks after baseline. Results In multivariate analysis, youth awareness of HIV status, caregiver not fully responsible for medications, low caregiver well-being, adolescent perceptions of poor caregiver–youth relations, caregiver perceptions of low social support, and African American ethnicity were associated with nonadherence over 48 weeks. Conclusions Interventions focusing on caregivers and their interactions with the individual youth and extrafamilial system should be prioritized for prevention and treatment efforts to address nonadherence during the transition into adolescents.
ACCESSION #
88989061

 

Related Articles

  • Adherence to Both Cotrimoxazole and Placebo is Associated with Improved Survival Among HIV-Infected Zambian Children. Walker, A. Sarah; Ford, Deborah; Mulenga, Veronica; Thomason, Margaret J.; Nunn, Andrew; Chintu, Chifumbe; Gibb, Diana M.; Bangsberg, David R. // AIDS & Behavior;Feb2009, Vol. 13 Issue 1, p33 

    In the CHAP randomized placebo-controlled trial of cotrimoxazole prophylaxis in HIV-infected Zambian children conducted between 2001 and 2003, cotrimoxazole was associated with significant mortality reductions. In a secondary analysis we used Cox regression models to estimate the association...

  • CE/CME questions.  // AIDS Alert;Oct2007, Vol. 22 Issue 10, p119 

    A quiz about HIV infection and its treatment is presented.

  • Infectious diseases. Segreti, John // Patient Care;1/15/1998, Vol. 32 Issue 1, p102 

    Presents a study entitled `Antiretroviral Therapy for HIV Infection in 1997: Updated Recommendations of the International AIDS Society--USA Panel,' by CCJ Carpenter, MA Fischl, SM Hammer, et al in the 1997 issue of the JAMA.

  • Daily Dosing of Highly Active Antiretroviral Therapy. Rosenbach, Keith A.; Allison, Robert; Nadler, Jeffrey P. // Clinical Infectious Diseases;3/1/2002, Vol. 34 Issue 5, p686 

    Reviews a strategy for developing medications and regimens for the management of HIV infection that can be taken once per day. Goal of the strategy; Comparison of regimen with two or three times daily dosing with a regimen with once-daily dosing; Findings from studies of regimens with...

  • Effect of Potent Antiretroviral Therapy on Immune Responses to Mycobacterium avium in Human Immunodeficiency Virus-Infected Subjects. Havlir, Diane V.; Schrier, Rachel D.; Torriani, Francesca J.; Chervenak, Keith; Hwang, Jimmy Y.; Boom, W. Henry // Journal of Infectious Diseases;12/1/2000, Vol. 182 Issue 6 

    To characterize the influence of highly active antiretroviral therapy (HAART) on cell-mediated immunity (CMI) to Mycobacterium avium complex (MAC), we measured immune responses to M. avium in human immunodeficiency virus (HIV)-infected individuals before and during HAART, in subjects with a...

  • From exceptionalism to normalisation: A reappraisal of attitudes and practice around HIV testing. De Cock, Kevin M.; Johnson, Anne M. // BMJ: British Medical Journal (International Edition);01/24/98, Vol. 316 Issue 7127, p290 

    Argues that earlier and more widespread diagnosis of human immunodeficiency virus (HIV) infection is needed for therapeutic interventions to full their potential. Discussion of the strategy term HIV/AIDS exceptionalism; Scientific advances concerning HIV/AIDS with major implications for...

  • Opioid substitution therapy in resource-poor settings. Kermode, Michelle; Crofts, Nick; Kumar, M. Suresh; Dorabjee, Jimmy // Bulletin of the World Health Organization;Apr2011, Vol. 89 Issue 4, p243 

    The authors reflect on opioid substitution therapy in resource-poor settings. They suggests that despite evidence which shows that opioid substitution therapies are effective, only eight percent of injecting drug users globally currently receive opioid substitution therapy and less than eight...

  • Value of Patient Self-Report and Plasma Human Immunodeficiency Virus Protease Inhibitor Level as Markers of Adherence to Antiretroviral Therapy: Relationship to Virologic Response. Duong, Michel; Piroth, Lionel; Forte, Fabien; Grappin, Michele; Buisson, Marielle; Chavanet, Pascal; Portier, Henri; Peytavin, Gilles; Kohli, Evelyne // Clinical Infectious Diseases;8/1/2001, Vol. 33 Issue 3, p386 

    Presents a study which evaluated methods of adherence to antiretroviral therapy for patients infected with HIV. Patients and methods; Results; Discussion.

  • Complementary HIV/AIDS therapies to be offered at six new sites.  // Gay & Lesbian Times;6/24/2004, Issue 861, p23 

    Announces the availability of the complementary HIV/AIDS therapies at sites in San Diego area, California.

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics